Key facts
- This page summarizes Mark Andrew Taylor's Form 3 filing for CDT Equity Inc. (CDT).
- 0 reported transactions and 3 derivative rows are listed below.
- Accepted by SEC: 30 Mar 2026, 21:22.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
These shares of common stock, par value $0.0001 per share ("Common Stock"), of CDT Equity Inc. (the "Issuer") and pre-funded warrants (the "Pre-Funded Warrants") to purchase shares of Common Stock are held directly by Prospect Capital Securities Limited ("Prospect Capital") and Prospect Finance Limited ("Prospect Finance"), and were received as consideration pursuant to the terms of that certain Securities Purchase Agreement, dated February 19, 2026 (the "Purchase Agreement"), by and among the Issuer and the stockholders of Sarborg Limited ("Sarborg"), including Prospect Capital and Prospect Finance. Pursuant to the Purchase Agreement, Prospect Capital received 198,749 shares of Common Stock and Pre-Funded Warrants to purchase up to 36,551,817 shares of Common Stock in exchange for 339 Sarborg Shares and Prospect Finance received 127,209 shares of Common Stock and Pre-Funded Warrants to purchase up to 24,578,432 shares of Common Stock in exchange for 218 Sarborg Shares.
Footnote F2
Mark Taylor is the sole director and sole shareholder of each of Prospect Capital and Prospect Finance. By virtue of these relationships, Mr. Taylor may be deemed to beneficially own the securities held of record by each of Prospect Capital and Prospect Finance. Mr. Taylor disclaims any such beneficial ownership except to the extent of his pecuniary interest therein.
Footnote F3
The exercisability of the Pre-Funded Warrants is subject to shareholder approval and a 49.99% beneficial ownership limitation. The Pre-Funded Warrants have no expiration date and are to be exercisable, once approved by the shareholders of the Issuer, until exercised in full.